Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Featured resources and latest news from the Exchanges blog


WHO to Review Risk of HIV Acquisition with Hormonal Contraception
The World Health Organization will convene an expert group to assess its current guidance on use of hormonal contraception by women at risk of HIV acquisition given an updated systematic rev...

Keeping Male Contraceptive Research Front and Center
Novel approaches, identification of new genetic targets, and more expansive acceptability research could lead to development of new male contraceptives in our lifetime.

Calliope, the Contraceptive Pipeline Database
Calliope, the Contraceptive Pipeline Database, provides information on new and future contraceptive products, including long-acting and novel products currently only available in li...

CDC Updates Contraceptive Use Recommendations
The U.S. Centers for Disease Control and Prevention (CDC) has updated two key guidance documents on contraceptive use.

Making New Male Contraceptives a Reality
Slow, steady progress is being made in male contraceptive research but important challenges still need to be addressed.

Genetic and Small Molecule Advances Bode Well for Male Contracept...
Recent advances suggest that development of a non-hormonal male contraceptive may be possible.

New Male Contraceptives: What’s in the Near-term Pipeline?
The ability of scientists to discover ways to keep sperm production at bay will be instrumental in significantly changing the contraceptive landscape for men.

It Takes Two: How Men Fit into Expanding the FP Method Mix
Not only would new male contraceptives add to the method mix, they would give men an opportunity to take a more proactive and equitable role in their own reproductive health and that of thei...

Beyond Condoms and Vasectomies: What’s Happening with Male Con...
Novel male contraceptives under development always seem to be "a decade away" from market introduction. In this 5-part series, the challenges of male contraceptive research will be explored...

What Goes in, Must Come Out
Contraceptive implants are available to more women around the world than ever before. Access to quality, timely, and affordable removal services when desired must also be ensured.

When “the Longer, the Better” is Best: Extended Use of LARCs
While Implanon®, a contraceptive implant, is currently labeled for three years of use and Mirena®, a levonorgestrel-releasing intrauterine system (LNG-IUS), is labeled for five years, clin...

Essential Reproductive & Maternal Health Commodities Database Lau...
Wanting a way to track critical reproductive and maternal health (RMH) commodities found in national essential medicine lists (EML), a partnership of advocacy groups has launched a new tool,...


We want you to join the exchange!


The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback